To include your compound in the COVID-19 Resource Center, submit it here.

Passage to India

BB Biotech makes first investments in India: Glenmark, Lupin, Strides Arcolab

Lured by strong market growth prospects and diversified risk portfolios, BB Biotech AG pulled the trigger on its first investments in Indian biotechs last quarter. The three new portfolio companies - Glenmark Pharmaceuticals Ltd., Lupin Ltd. and Strides Arcolab Ltd. - each offer a different ratio of innovator to generic products.

In its 2Q report to shareholders last week, BB Biotech expressed confidence that

Read the full 631 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers